共 95 条
[1]
Grunblatt E.(2001)Gene expression analysis in J Neurochem 78 1-12
[2]
Mandel S.(2003)-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson’s disease using cDNA microarray: effect of R-apomorphine Lancet Neurol 2 531-538
[3]
Maor G.(2004)The environment and Parkinson’s disease: is the nigrostriatal system preferentially targeted by neurotoxins? Nat Med 10 S58-S62
[4]
Youdim M.B.(2006)Genetic clues to the pathogenesis of Parkinson’s disease Neurology 66 S10-S23
[5]
Di Monte D.A.(2004)Etiology of Parkinson’s disease Nat Rev Drug Discov 3 205-214
[6]
Vila M.(2006)Neurodegenerative diseases and oxidative stress Ann Pharmacother 40 935-938
[7]
Przedborski S.(2005)Antioxidants, supplements, and Parkinson’s disease Exp Neurol 193 279-290
[8]
Schapira A.H.(2002)Oxidative stress and inflammation in Parkinson’s disease: is there a causal link? Nat rev Neurosci 3 932-942
[9]
Barnham K.J.(2003)Pathogenesis of Parkinson’s disease: dopamine, vesicles and α-synuclein Ann Neurol 53 S26-S38
[10]
Masters C.L.(2006)Oxidative stress in Parkinson’s disease Neurobiol Dis 23 120-126